Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation

Overview

Journal Cardiol Res Pract

Publisher Wiley

Specialty Cardiology & Vascular Diseases

Date 2016 Mar 12

PMID 26966608

Citations 4

Authors

Yogita M Rochlani

Nishi N Shah

Naga V Pothineni

Hakan Paydak

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is a common arrhythmia in adults associated with thromboembolic complications. External electrical cardioversion (DCCV) is a safe procedure used to convert AF to normal sinus rhythm. We sought to study factors that affect utilization of DCCV in hospitalized patients with AF. The study sample was drawn from the Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project in the United States. Patients with a primary discharge diagnosis of AF that received DCCV during hospitalization in the years 2000-2010 were included. An estimated 2,810,530 patients with a primary diagnosis of AF were hospitalized between 2001 and 2010, of which 1,19,840 (4.26%) received DCCV. The likelihood of receiving DCCV was higher in patients who were males, whites, privately insured, and aged < 40 years and those with fewer comorbid conditions. Higher CHADS2 score was found to have an inverse association with DCCV use. In-hospital stroke, in-hospital mortality, length of stay, and cost for hospitalization were significantly lower for patients undergoing DCCV during AF related hospitalization. Further research is required to study the contribution of other disease and patient related factors affecting the use of this procedure as well as postprocedure outcomes.

Citing Articles

Hospital Utilization and Mortality Post-electrical Cardioversion in Patients With Atrial Fibrillation in a Community Hospital.

Jain A, Borz-Baba C, Wakefield D Cureus. 2024; 16(8):e66919.

PMID: 39280380 PMC: 11401630. DOI: 10.7759/cureus.66919.

Sex-Differences in Atrial Fibrillation Patients: Bias or Proper Management?.

Israeli A, Gal D, Younis A, Ehrenberg S, Rozner E, Turgeman Y Vasc Health Risk Manag. 2022; 18:347-358.

PMID: 35546968 PMC: 9084509. DOI: 10.2147/VHRM.S366285.

Women and atrial fibrillation.

Volgman A, Benjamin E, Curtis A, Fang M, Lindley K, Naccarelli G J Cardiovasc Electrophysiol. 2020; 32(10):2793-2807.

PMID: 33332669 PMC: 8281363. DOI: 10.1111/jce.14838.

Urban-rural differences in mortality for atrial fibrillation hospitalizations in the United States.

ONeal W, Sandesara P, Kelli H, Venkatesh S, Soliman E Heart Rhythm. 2017; 15(2):175-179.

PMID: 29241636 PMC: 5801039. DOI: 10.1016/j.hrthm.2017.10.019.

References

Brinjikji W, El-Sayed A, Kallmes D, Lanzino G, Cloft H . Racial and insurance based disparities in the treatment of carotid artery stenosis: a study of the Nationwide Inpatient Sample. J Neurointerv Surg. 2014; 7(9):695-702. DOI: 10.1136/neurintsurg-2014-011294. View

Hagens V, Vermeulen K, Tenvergert E, Van Veldhuisen D, Bosker H, Kamp O . Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J. 2004; 25(17):1542-9. DOI: 10.1016/j.ehj.2004.06.020. View

January C, Samuel Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland Jr J . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1-76. DOI: 10.1016/j.jacc.2014.03.022. View

Rolf S, Kornej J, Dagres N, Hindricks G . What can rhythm control therapy contribute to prognosis in atrial fibrillation?. Heart. 2015; 101(11):842-6. DOI: 10.1136/heartjnl-2013-305152. View

Ionescu-Ittu R, Abrahamowicz M, Jackevicius C, Essebag V, Eisenberg M, Wynant W . Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med. 2012; 172(13):997-1004. DOI: 10.1001/archinternmed.2012.2266. View

Talajic M, Khairy P, Levesque S, Connolly S, Dorian P, Dubuc M . Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol. 2010; 55(17):1796-802. DOI: 10.1016/j.jacc.2010.01.023. View

Potpara T, Marinkovic J, Polovina M, Stankovic G, Seferovic P, Ostojic M . Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol. 2011; 161(1):39-44. DOI: 10.1016/j.ijcard.2011.04.022. View

Colilla S, Crow A, Petkun W, Singer D, Simon T, Liu X . Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013; 112(8):1142-7. DOI: 10.1016/j.amjcard.2013.05.063. View

Pothineni N, Deshmukh A, Pant S, Patel N, Badheka A, Chothani A . Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trials. Int J Cardiol. 2014; 175(2):372-3. DOI: 10.1016/j.ijcard.2014.04.250. View

10.

Dagres N, Nieuwlaat R, Vardas P, Andresen D, Levy S, Cobbe S . Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007; 49(5):572-7. DOI: 10.1016/j.jacc.2006.10.047. View

11.

Kapoor J, Kapoor R, Hellkamp A, Hernandez A, Heidenreich P, Fonarow G . Payment source, quality of care, and outcomes in patients hospitalized with heart failure. J Am Coll Cardiol. 2011; 58(14):1465-71. PMC: 4603423. DOI: 10.1016/j.jacc.2011.06.034. View

12.

Thomas K, Piccini J, Liang L, Fonarow G, Yancy C, Peterson E . Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. J Am Heart Assoc. 2013; 2(5):e000200. PMC: 3835220. DOI: 10.1161/JAHA.113.000200. View

13.

Patel N, Deshmukh A, Pant S, Singh V, Patel N, Arora S . Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014; 129(23):2371-9. DOI: 10.1161/CIRCULATIONAHA.114.008201. View

14.

Rienstra M, Van Veldhuisen D, Hagens V, Ranchor A, Veeger N, Crijns H . Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005; 46(7):1298-306. DOI: 10.1016/j.jacc.2005.05.078. View

15.

Wyse D, Waldo A, DiMarco J, Domanski M, Rosenberg Y, Schron E . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347(23):1825-33. DOI: 10.1056/NEJMoa021328. View

16.

Deshmukh A, Pant S, Kumar G, Bursac Z, Paydak H, Mehta J . Comparison of outcomes of weekend versus weekday admissions for atrial fibrillation. Am J Cardiol. 2012; 110(2):208-11. DOI: 10.1016/j.amjcard.2012.03.011. View

17.

Bhave P, Lu X, Girotra S, Kamel H, Vaughan Sarrazin M . Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015; 12(7):1406-12. PMC: 4787261. DOI: 10.1016/j.hrthm.2015.03.031. View

18.

Naderi S, Rodriguez F, Wang Y, Foody J . Racial disparities in hospitalizations, procedural treatments and mortality of patients hospitalized with atrial fibrillation. Ethn Dis. 2014; 24(2):144-9. View